Search for Clinical Trial Results

Sponsored By

Microscopic Polyangiitis - 25 Studies Found

Status Study
Recruiting Study Name: CHUSPAN PAN BP Treatment of Polyarteritis Nodosa and Microscopic Polyangiitis Without Poor-Prognosis Factors
Condition:
  • Polyarteritis Nodosa
  • Microscopic Polyangiitis

Date: 2006-11-14
Interventions:
  • Drug: azathioprine
  • Drug: cyclophosphamide
Active, not recruiting Study Name: An Observational Study of The Safety of MabThera/Rituxan (Rituximab) in Patients With Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition:
  • Granulomatosis With Polyangiitis
  • Microscopic Polyangiitis

    • Date: 2012-06-04
    Interventions: Drug: Rituximab Participants received rituximab at the discretion of their treating physicians.
Recruiting Study Name: Longitudinal Protocol for Granulomatosis With Polyangiitis (Wegener's) and Microscopic Polyangiitis
Condition:
  • Granulomatosis With Polyangiitis
  • Microscopic Polyangiitis

    • Date: 2006-04-14
Completed Study Name: CellCept in p-ANCA Vasculitis
Condition:
  • MPO-ANCA Vasculitis
  • Microscopic Polyangiitis

Date: 2006-11-29
Interventions: Drug: CellCept (mycophenolate mofetil)
Recruiting Study Name: A Study Evaluating the Safety and Efficacy of Rituximab in Combination With Glucocorticoids in Participants With Wegener's Granulomatosis or Microscopic Polyangitis
Condition: Wegener's Granulomatosis or Microscopic Polyangiitis
Date: 2014-04-14
Interventions:
  • Drug: Methylprednisolone Methy
Completed Study Name: Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
Condition:
  • Vasculitis
  • Wegener's Granulomatosis

  • Date: 2005-02-24
    Interventions:
    • Drug: Rituximab plus cyclophosphamide placebo (rituximab group)

Active, not recruiting Study Name: A Phase IIa Study of Intravenous Rituximab in Pediatric Participants With Severe Granulomatosis With Polyangiitis (Wegener's) or Microscopic Polyangiitis
Condition: Granulomatosis With Polyangiitis
Date: 2012-12-13
Interventions: Drug: Rituximab Participants will receive rituximab 375 mg/m^2 IV infusion on Days 1, 8, 15 and 22. Ritu
Withdrawn Study Name: BIANCA-SC: A Study of the Efficacy, Safety, and Tolerability of Blisibimod in Addition to Methotrexate During Induction of Remission in Subjects With ANCA-Associated Small Vessel Vasculitis
Condition:
  • Granulomatosis With Polyangiitis
  • Microscopic Polyangiitis

    • Date: 2012-05-11
    Interventions:
    • Drug: Blisibimod
    • Drug: Placebo
Completed Study Name: Association Corticosteroid/Azathioprine in Microscopic Polyangiitis/ Polyarteritis Nodosa or Eosinophilic Granulomatosis With Polyangiitis (Churg Strauss Syndrome)
Condition:
  • MPA
  • PAN or EGPA With FFS=0
  • At Diagnosis or Within the Firs
    Date: 2008-03-26
    Interventions:
    • Drug: corticosteroid and azathioprine

Completed Study Name: Efficacy Study of Two Treatments in the Remission of Vasculitis
Condition:
  • Wegener's Granulomatosis,
  • Microscopic Polyangiitis

Date: 2008-09-05
Interventions:
  • Drug: Rituximab

Next >>>